
Nectar Lifescience Ltd is Rated Strong Sell
2026-11-18 10:11:06Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Nectar Lifescience Ltd Reports Negative Financial Trend Amidst Mixed Quarterly Performance
2026-11-17 11:00:06Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its financial trend for the quarter ended September 2026. Despite posting its highest quarterly PAT in recent history, the company’s overall financial health has weakened, with key profitability and efficiency metrics showing significant contraction compared to historical averages.
Read More
Nectar Lifescience Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight
2026-10-30 14:00:08At Rs 9.82, sellers were still queuing — but there were no buyers willing to take the other side. Nectar Lifescience Ltd locked at its lower circuit of 5% on 29 Oct 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.
Read MoreNectar Lifescience Ltd Falls 2.09%: 3 Key Factors Driving the Weekly Decline
2026-10-25 14:00:09Key Events This Week Oct 19: Stock surged to upper circuit at Rs.11.07 (+4.93%) Oct 21: Another upper circuit hit at Rs.11.61 (+4.97%) Oct 23: Shares hit lower circuit amid heavy selling, closing at Rs.10.33 (-4.17%) Week OpenRs.10.55 Week CloseRs.10.33-2.09% <div cl...
Read More
Nectar Lifescience Ltd Locks at Upper Circuit With 4.93% Gain — Buyers Queue, Sellers Absent
2026-10-19 10:00:10At Rs 11.06, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nectar Lifescience Ltd locked at its upper circuit of 4.93% on 19 Oct 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Nectar Lifescience Ltd Locks at Upper Circuit With 4.98% Gain — Buyers Queue, Sellers Absent
2026-10-16 11:00:10At Rs 10.54, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nectar Lifescience Ltd locked at its upper circuit of 4.98% on 15 Oct 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Nectar Lifescience Ltd is Rated Strong Sell
2026-10-16 10:10:25Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 October 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreNectar Lifescience Ltd Falls 4.16%: 2 Key Circuit Events Shape the Week
2026-10-11 13:00:05Key Events This Week 5 Oct: Week opens at ₹10.57 6 Oct: Hits upper circuit amid strong buying pressure (₹11.00) 7 Oct: Sharp correction with 3.90% decline (₹10.60) 8 Oct: Continued weakness, down 1.13% (₹10.48) 9 Oct: Hits lower circuit amid heavy selling pressure (₹10.13) Week OpenRs.10.57 <div class="s...
Read More
Nectar Lifescience Ltd Locks at Lower Circuit With 2.75% Loss — Sellers Queue, No Buyers in Sight
2026-10-09 15:00:07At Rs 10.03, sellers were still queuing — but there were no buyers willing to take the other side. Nectar Lifescience Ltd locked at its lower circuit of 2.75% on 9 Oct 2026, with unfilled sell orders and a frozen price.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSENectar Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication
Results For Quarter And Half Year Ended September 30 2026.
14-Nov-2026 | Source : BSEPlease find attached herewith Results For Quarter And Half Year Ended September 30 2026.
Board Meeting Intimation for Financial Result And Other Business Matters
06-Nov-2026 | Source : BSENectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve unaudited financial results for the period ended September 30 2026 and other business matters
Corporate Actions
No Upcoming Board Meetings
Nectar Lifescience Ltd has declared 5% dividend, ex-date: 11 Sep 20
Nectar Lifescience Ltd has announced 1:10 stock split, ex-date: 12 Nov 08
No Bonus history available
No Rights history available